News

Lilavati Hospital Is Taking Indian Healthcare to Kazakhstan — A Super-Speciality OPD in Central Asia Is India's Medical Tourism Going North

By Mustafa Shariff, Editor in Chief · August 17,2026 · 2 min read

Mustafa Shariff, Editor in Chief — Lilavati Hospital Is Taking Indian Healthcare to Kazakhstan — A Super-Speciality OPD in Central Asia Is India's Medical Tourism Going North

Summary

  • Lilavati Hospital Launches Super-Speciality OPD in Kazakhstan — India's Medical Tourism Ecosystem Expands Into Central Asia
  • Lilavati Hospital, one of Mumbai's most prestigious multi-specialty hospitals, is launching a Super-Speciality OPD in Kazakhstan — the first significant expansion of top-tier Indian hospital clinical presence into Central Asia.

"Kazakhstan represents an exciting new frontier for Indian healthcare. Central Asian patients have historically had limited access to the kind of super-speciality care that Indian hospitals provide — they have travelled to Europe, Russia, or Turkey for complex procedures. Lilavati Hospital's Super-Speciality OPD in Kazakhstan will bring Indian clinical expertise closer to these patients, offering specialist consultations and facilitating referrals to Mumbai for complex interventions. This is India's healthcare going to the patient, not waiting for the patient to come to India."

Lilavati Hospital and Research Centre, one of Mumbai's most prestigious multi-specialty private hospitals, has announced its plans to launch a Super-Speciality Outpatient Department in Kazakhstan — a move that takes a top-tier Indian hospital's clinical presence into Central Asia for the first time and extends India's medical tourism ecosystem into a geography that has historically sourced complex specialist care from European, Russian, and Turkish medical destinations.
Lilavati Hospital's core strength has been built around complex tertiary care: transplantation programmes (kidney, liver, bone marrow), cardiac interventions, neurosurgery, oncology, and other high-acuity specialties that require the combination of experienced specialist physicians, advanced diagnostic infrastructure, and intensive care capabilities that tier-1 Indian hospitals provide. The hospital has an established international patient programme serving GCC, African, and South Asian patients — experience that provides the operational template for extending into Kazakhstan.
Kazakhstan's Healthcare Context
Kazakhstan — with a population of approximately 19 million, a GDP per capita approaching $10,000, and a rapidly expanding private sector economy — has built a healthcare system that handles primary and secondary care well but continues to send patients abroad for complex specialist procedures. The government has invested in its domestic healthcare infrastructure under successive development programmes, but the gap between what Kazakhstan's specialist medical community can provide and what international best-practice tertiary care looks like remains significant for the most complex cases.
Historically, Kazakhstani patients seeking complex specialist care have travelled primarily to Germany (for cardiac and neurosurgery), Russia (for oncology and transplantation, and proximity), South Korea (for oncology and cosmetic surgery), Turkey (as a cost-effective European alternative), and increasingly, to India (particularly for transplantation, cardiac surgery, and cancer care). India's value proposition for Kazakhstani patients is similar to its positioning with GCC patients: clinical quality comparable to Western European hospitals at 30-50% of the cost, shorter waiting times, and significant English language capability among the specialist physician community.
The Super-Speciality OPD Model
The Super-Speciality OPD model — rather than a full hospital — is the operationally and commercially appropriate entry strategy for an Indian hospital going into a new international market. An OPD enables specialist consultations in the local market, specialist-to-specialist liaison with referral coordination, and diagnostic assessment — without requiring the capital investment and regulatory burden of establishing a full acute care hospital in a foreign jurisdiction.
From the OPD, patients whose cases require hospital-level interventions can be referred and facilitated to travel to Lilavati Hospital in Mumbai for the procedure itself — creating a referral pipeline that generates international patient revenue for the Mumbai flagship while establishing Lilavati's clinical brand in Kazakhstan. This is the same hub-and-spoke model that large global hospital chains like Cleveland Clinic (with its Abu Dhabi hospital) and Singapore's Parkway Pantai (across Southeast Asia) have used to extend their geographic brand reach.
India's Medical Tourism Expanding North
India's medical tourism ecosystem has traditionally focused on GCC countries (Saudi Arabia, UAE, Kuwait, Bahrain, Qatar, Oman), East Africa, and South Asian neighbours (Bangladesh, Nepal, Sri Lanka, Afghanistan) as its primary international patient sources. The Lilavati Kazakhstan OPD announcement is part of a broader trend of Indian hospitals looking north and west: to Central Asia, the Caucasus, and the former Soviet space where income levels are rising, healthcare quality gaps persist, and Indian clinical expertise offers compelling value.
India's government has been actively supporting this trajectory through its healthcare services export agenda and through the five Regional Medical Hubs proposed in Union Budget 2026-27 (covered BHC Media July 27 edition) — designed to create the infrastructure for India's medical tourism ecosystem to scale beyond its current base.
BHC Perspective
At Bengaluru Health Community, Lilavati Hospital's Kazakhstan OPD is an India healthcare going-international story that reflects the growing confidence of India's private hospital sector in competing for international patients beyond traditional markets. For BHC founders building international patient coordination, medical translation, or cross-border health services technology — the Kazakhstan OPD model represents exactly the kind of hospital international expansion that creates demand for your platforms.
Frequently Asked Questions
Q: What is Lilavati Hospital doing in Kazakhstan?
A: Launching a Super-Speciality Outpatient Department — enabling specialist consultations in Kazakhstan, with complex cases referred to Lilavati's Mumbai flagship for hospital-level procedures. One of the first significant expansions of top-tier Indian hospital clinical presence into Central Asia.
Q: Why Kazakhstan?
A: 19 million population, rising middle class, healthcare infrastructure gap for complex specialist care. Kazakhstani patients historically travel to Germany, Russia, Turkey, and South Korea for tertiary care — India's combination of clinical quality, cost efficiency, and zero waiting time creates a compelling alternative.
Q: What is the Super-Speciality OPD model?
A: Specialist consultations and diagnostic assessment in the local market, with facilitated referral to the Mumbai flagship for complex hospital-level interventions. Capital-efficient international market entry model similar to Cleveland Clinic (Abu Dhabi), Parkway Pantai (Southeast Asia) — building brand and referral pipeline without full hospital investment.